Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
05. Februar 2019 05:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit...
Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry
04. Dezember 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, released an open letter from Nu-Med Plus...
Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent
14. November 2018 12:07 ET
|
Nu-Med Plus Inc.
Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions SALT LAKE CITY, Nov. 14, 2018 (GLOBE NEWSWIRE) --...
Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry
09. Oktober 2018 07:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces a new articulation of the...
Nu-Med Plus, Inc. announces Vice President of Medical Marketing discusses the exciting future of Nitric Oxide
26. September 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Brett Earl, Vice...
Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study
11. September 2018 07:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Ronald Day, a...
Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market
14. August 2018 09:00 ET
|
Nu-Med Plus Inc.
Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products SALT LAKE CITY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a...
Nu-Med Plus, Inc. Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval
31. Juli 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-Med Plus, Inc. Selects s2s Public Relations firm as its Strategic Partner
26. Juni 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, June 26, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which investigates and develops nitric oxide applications of new technologies in the...
Nu-Med Plus, Inc. engages Millennium Biosciences for Quality and Regulatory consulting services
12. Juni 2018 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, June 12, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical...